T. Rowe Price Associates’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-189,491
| Closed | -$6.03M | – | 2963 |
|
|
2023
Q4 | $6.03M | Sell |
189,491
-11,227
| -6% | -$358K | ﹤0.01% | 1168 |
|
|
2023
Q3 | $7.08M | Sell |
200,718
-50,380
| -20% | -$1.78M | ﹤0.01% | 1122 |
|
|
2023
Q2 | $9.55M | Hold |
251,098
| – | – | ﹤0.01% | 1081 |
|
|
2023
Q1 | $9.48M | Hold |
251,098
| – | – | ﹤0.01% | 1070 |
|
|
2022
Q4 | $10.6M | Sell |
251,098
-1,100
| -0.4% | -$46.6K | ﹤0.01% | 1037 |
|
|
2022
Q3 | $8.1M | Hold |
252,198
| – | – | ﹤0.01% | 1099 |
|
|
2022
Q2 | $8.19M | Sell |
252,198
-1,235,837
| -83% | -$40.2M | ﹤0.01% | 1347 |
|
|
2022
Q1 | $53.8M | Sell |
1,488,035
-214,996
| -13% | -$7.78M | 0.01% | 945 |
|
|
2021
Q4 | $67.4M | Sell |
1,703,031
-106,547
| -6% | -$4.22M | 0.01% | 895 |
|
|
2021
Q3 | $79.1M | Sell |
1,809,578
-182,863
| -9% | -$7.99M | 0.01% | 844 |
|
|
2021
Q2 | $81.4M | Buy |
1,992,441
+39,357
| +2% | +$1.61M | 0.01% | 865 |
|
|
2021
Q1 | $64.1M | Buy |
1,953,084
+1,536,846
| +369% | +$50.5M | 0.01% | 911 |
|
|
2020
Q4 | $16.9M | Buy |
416,238
+263,788
| +173% | +$10.7M | ﹤0.01% | 1255 |
|
|
2020
Q3 | $5.58M | Buy |
+152,450
| New | +$5.58M | ﹤0.01% | 1391 |
|
|
2019
Q4 | – | Sell |
-21,613
| Closed | -$438K | – | 2528 |
|
|
2019
Q3 | $438K | Buy |
+21,613
| New | +$438K | ﹤0.01% | 2140 |
|